Roblitinib - FGF 401 | NVP-FGF401

Based on 4 reference(s) in Google Scholar 8 10 4

Axon 2953

CAS [1708971-55-4]

MF C25H30N8O4
MW 506.56

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO



Roblitinib is a first-in-class, highly selective and potent FGFR4 inhibitor with an IC50 value of 1.1 nM. Roblitinib binds in a reversible covalent manner to the FGFR4 kinase domain. Developed for hepatocellular carcinoma and currently undergoing clinical evaluation for the treatment of FGFR4 and β-klotho positive solid tumors.

KEYWORDS: Roblitinib | supplier | FGFR4 inhibitor | FGF 401 | NVP-FGF401 | FGF401 | FGF-401 | NVPFGF401 | NVP FGF401 | CAS [1708971-55-4] | FGF | FGFR | Inhibitor | Receptors | HCC

Size Unit Price Stock
5 mg €125.00 In Stock
25 mg €450.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €200.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...